DecisionDx-Melanoma Gene Expression Test Improves Risk Prediction Beyond Standard Staging
Data from nearly 1,900 SEER-linked patients show the test identifies meaningful survival differences within the same AJCC stage.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Melanoma |
Data from nearly 1,900 SEER-linked patients show the test identifies meaningful survival differences within the same AJCC stage.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Prostate |
The updated urine test utilizes machine learning and patient ethnicity to provide individualized risk scores for aggressive disease.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Infectious Diseases |
Thirty-one test orders are currently listed as unavailable, requiring labs to seek alternative testing pathways or coordinate with public health partners.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Cervical (HPV) |
A new survey-based study finds that more than half of physically Disabled women would prefer at-home human papillomavirus testing over traditional clinic-based cervical screening.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Infectious Diseases |
The test identifies antibodies associated with active disease, potentially offering a faster alternative to sputum samples and existing screening methods.
Read More